ProPharma Group Acquires M Squared Associates

March 16, 2022

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired M Squared Associates, a clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry. The acquisition expands ProPharma's med‑tech capabilities across clinical affairs, regulatory strategy and quality systems, enabling broader end‑to‑end support for device, combination product and diagnostic clients globally.

Buyers
ProPharma Group, Odyssey Investment Partners
Targets
M Squared Associates
Platforms
ProPharma Group
Location
United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.